Cargando…
The trans-membrane domain of Bcl-2α, but not its hydrophobic cleft, is a critical determinant for efficient IP(3) receptor inhibition
The anti-apoptotic Bcl-2 protein is emerging as an efficient inhibitor of IP(3)R function, contributing to its oncogenic properties. Yet, the underlying molecular mechanisms remain not fully understood. Using mutations or pharmacological inhibition to antagonize Bcl-2's hydrophobic cleft, we ex...
Autores principales: | Ivanova, Hristina, Ritaine, Abigael, Wagner, Larry, Luyten, Tomas, Shapovalov, George, Welkenhuyzen, Kirsten, Seitaj, Bruno, Monaco, Giovanni, De Smedt, Humbert, Prevarskaya, Natalia, Yule, David I., Parys, Jan B., Bultynck, Geert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342447/ https://www.ncbi.nlm.nih.gov/pubmed/27494888 http://dx.doi.org/10.18632/oncotarget.11005 |
Ejemplares similares
-
Allosteric cross-talk between the hydrophobic cleft and the BH4 domain of Bcl-2 in control of inositol 1,4,5-trisphosphate receptor activity
por: Shapovalov, George, et al.
Publicado: (2022) -
Alpha-Helical Destabilization of the Bcl-2-BH4-Domain Peptide Abolishes Its Ability to Inhibit the IP(3) Receptor
por: Monaco, Giovanni, et al.
Publicado: (2013) -
Organelle membrane derived patches: reshaping classical methods for new targets
por: Shapovalov, George, et al.
Publicado: (2017) -
IP(3) Receptors, Mitochondria, and Ca(2+) Signaling: Implications for Aging
por: Decuypere, Jean-Paul, et al.
Publicado: (2011) -
mTOR-Controlled Autophagy Requires Intracellular Ca(2+) Signaling
por: Decuypere, Jean-Paul, et al.
Publicado: (2013)